PFE made a smart move, halted the failed trial and now will let AXON waste their money. So somehow longs here think AXON knows something that PFE doesn't? Please...chance of AXON success is now between zero and none.
The only thing I recall that was a tiny issue was the QT interval , If I am not mistaken Pima caused a slight delay, ie prolongation, its been so long I dont even remember what the final result was. Geez.
well give me address to submit a poem to LZ site. I will contact you. Your site uses Outlook, and believe it or not I don't have it.
I know i could be totally wrong too-this could be a good trade today, but the pressures will come to light as time goes on.Good luck.
My take is sell the news at some point, maybe tomorrow. Generic drug maker with a specialty delivery, - reminds me of MNKD. Low float making this move . Note there is a lot of generic competition that will pressure the sales and I am concerned the drug insurance Payers will block most sales at the pharmacy window with their criteria and Brand Name Co-Pays, or they will either not pay for the Rx, no matter how many Rx are written by doc's. Good luck.